Multiple sclerosis

@article{Compston1994MultipleS,
  title={Multiple sclerosis},
  author={A. Compston and A. Coles},
  journal={The Lancet},
  year={1994},
  volume={359},
  pages={1221-1231}
}
  • A. Compston, A. Coles
  • Published 1994
  • Medicine
  • The Lancet
    • Differences in the risk of multiple sclerosis depending on racial background, and the high clinical concordance rates in monozygotic compared with dizygotic twins, have stimulated attempts to identify and locate genes that confer susceptibility to the disease. The risk of multiple sclerosis is increased from 1 in 800 in northern European Caucasians to 1 in 3 in the monozygotic co-twins of affected individuals, with intermediate rates for siblings, offspring and more distant relatives… CONTINUE READING
    View on Elsevier
    direct-ms.org

    References

    SHOWING 1-10 OF 19 REFERENCES
    The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course.
    • 573
    Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation.
    • 333
    The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability.
    • 1,445
    • PDF
    Plaque-associated expression of human herpesvirus 6 in multiple sclerosis.
    • P. Challoner, K. Smith, +7 authors M. Chang
    • Biology, Medicine
    • Proceedings of the National Academy of Sciences of the United States of America
    • 1995
    • 628
    • PDF
    A comparison of the pathology of primary and secondary progressive multiple sclerosis.
    • 286
    Overview of azathioprine treatment in multiple sclerosis
    • 210
    Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group.
    • Medicine
    • Neurology
    • 1995
    • 311
    Beta interferon and multiple sclerosis: why the fuss?
    • C. Mumford
    • Medicine
    • QJM : monthly journal of the Association of Physicians
    • 1996
    • 8
    • PDF
    Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2
    • 668
    Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis
    • 2,356
    • PDF